review Open AccessTop 1% cited
Biased agonism: An emerging paradigm in GPCR drug discovery
Bioorganic & Medicinal Chemistry Letters · 2015 · Vol. 26(2) · pp. 241–250
Zoran Ranković✉(Eli Lilly (United States))Tarsis F. Brust(Scripps Research Institute)Laura Bohn✉(Scripps Research Institute)
Receptor Mechanisms and SignalingNeuropeptides and Animal PhysiologyProtein Kinase Regulation and GTPase SignalingDruggabilityFunctional selectivityG protein-coupled receptorDrug discoveryArrestinComputational biologyEffectorSignal transductionChemistryNeuroscience
Citations
269
FWCI
12.05
field-weighted impact
References
125
Percentile
99%
vs. same field & year
Citations per year
References
How many drug targets are there?
Nature Reviews Drug Discovery · 2006 · 3,473 citations
Morphine Side Effects in β-Arrestin 2 Knockout Mice
Journal of Pharmacology and Experimental Therapeutics · 2005 · 601 citations
Functional Selectivity and Classical Concepts of Quantitative Pharmacology
Journal of Pharmacology and Experimental Therapeutics · 2006 · 1,103 citations
A G Protein-Biased Ligand at the μ-Opioid Receptor Is Potently Analgesic with Reduced Gastrointestinal and Respiratory Dysfunction Compared with Morphine
Journal of Pharmacology and Experimental Therapeutics · 2013 · 639 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.